Suscribirse

Treatment of large deep osteochondritis lesions of the knee by autologous matrix-induced chondrogenesis (AMIC): Preliminary results in 13 patients - 22/08/18

Doi : 10.1016/j.otsr.2018.05.008 
Pierre Bertho a, Adrien Pauvert b, Thomas Pouderoux c, Henri Robert b,
the

Orthopaedics and Traumatology Society of Western France (SOO)d

a Service d’orthopédie, CHU Pontchaillou, 2, rue Le Guilloux, 35033 Rennes, France 
b Service d’orthopédie, centre hospitalier Nord-Mayenne, 229, boulevard Paul-Lintier, 53100 Mayenne, France 
c Service d’orthopédie, CHU, 4, rue Larrey, 49100 Angers, France 
d Société d’orthopédie de l’ouest (SOO), 18, rue de Bellinière, 49800 Trélazé, France 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Osteochondral defects due to advanced osteochondritis of the knee eventually cause osteoarthritis. Autologous matrix-induced chondrogenesis (AMIC) may hold potential for overcoming the treatment challenges raised by defects larger than 2cm2. The primary objective of this study was to assess medium-term functional outcomes of AMIC. The secondary objective was to confirm the absence of adverse events.

Hypothesis

AMIC significantly improves knee function in patients with osteochondritis responsible for osteochondral defects grade III or IV in the International Cartilage Repair Society (ICRS) classification.

Material and methods

A total of 13 consecutive patients managed using AMIC between September 2011 and November 2016 were included in a prospective, single-centre, single-surgeon study. There were 8 males and 5 females with a mean age of 29 years (range, 15–51 years). Among them, 9 had had previous surgery. The ICRS grade was IV in 12 patients and III in 1 patient. The defects had a mean surface area of 3.7cm2 (range, 2.2–6.9cm2) and mean depth of 0.5mm (range, 0.4–0.8). In each patient, knee function was assessed by an independent examiner based on validated instruments (Knee injury and Osteoarthritis Outcome Score [KOOS], subjective International Knee Documentation Committee [IKDC] score, and visual analogue scale [VAS] pain score).

Results

After a median follow-up of 24 months (range, 12–42 months; minimum, 1 year), 11 patients had significant improvements, with mean increases in the IKDC score and KOOS of 27 and 28 points, respectively. The scores remained stable after the first year. Of the 2 patients with poorer outcomes, 1 had a history of multiple surgical procedures and the other was a 51-year-old female with a defect surface area of 6.9cm2. No post-operative complications were recorded.

Conclusion

AMIC is a reliable single-stage method that is both reproducible and widely available. AMIC significantly improves knee function scores in patients with large osteochondral defects due to advanced osteochondritis of the knee.

Level of evidence

IV, prospective cohort study.

El texto completo de este artículo está disponible en PDF.

Keywords : Knee, Osteochondritis, Autologous matrix-induced chondrogenesis, Chondro-Gide®, Microfracture


Esquema


 Article issued from the Orthopedics and Traumatology Society of Western France (SOO) – 2017 Tours meeting.


© 2018  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 104 - N° 5

P. 695-700 - septembre 2018 Regresar al número
Artículo precedente Artículo precedente
  • The influence of bone cement and American Society of Anesthesiologists (ASA) class on cardiovascular status during bipolar hemiarthroplasty for displaced femoral-neck fracture: A multicenter, prospective, case-control study
  • Shuichi Miyamoto, Junichi Nakamura, Satoshi Iida, Tomonori Shigemura, Shunji Kishida, Isao Abe, Munenori Takeshita, Makoto Otsuka, Yoshitada Harada, Sumihisa Orita, Seiji Ohtori
| Artículo siguiente Artículo siguiente
  • Anterior cruciate ligament reconstruction with the Tape Locking Screw (TLS) and a short hamstring graft: Clinical evaluation of 61 cases with a minimum 12 months’ follow-up
  • Benoît Orfeuvre, Régis Pailhé, Loïc Sigwalt, Brice Rubens Duval, Gabriel Lateur, Stéphane Plaweski, Dominique Saragaglia

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.